In April 2019, the FDA ordered manufacturers to stop selling/distributing surgical mesh for transvaginal Pelvic Organ Prolapse (POP) repair, as risks (pain, erosion, infection, reoperation) did not outweigh benefits.
transvaginal mesh fda safety communication